This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/kegg-drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/pubchem-substance/
n16http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/drugbank/
n18http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/chemspider/
n21http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n20http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/wikipedia/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/pharmgkb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/kegg-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04816/identifier/bindingdb/
n6http://linked.opendata.cz/resource/atc/
n5http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB04816
rdf:type
n3:Drug
n3:description
Withdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity.
n3:group
withdrawn investigational
owl:sameAs
n18:DB04816 n21:DB04816
dcterms:title
Dantron
adms:identifier
n8:11316 n9:3682 n10:46509077 n11:PA449206 n12:2950 n13:C10312 n14:D07107 n15:2845 n16:DB04816 n20:Danthron
n3:synonym
Chrysazin 1,8-dihydroxy-9,10-anthraquinone 1,8-dihydroxyanthra-9,10-quinone 1,8-Dihydroxyanthrachinon 1,8-Dihydroxyanthraquinone Danthron 1,8-dihydroxy-9,10-anthracenedione
n3:IUPAC-Name
n4:271B5628-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B562E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B562D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B562A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B562B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B562C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5626-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5624-363D-11E5-9242-09173F13E4C5 n4:271B5627-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5625-363D-11E5-9242-09173F13E4C5
n5:hasATCCode
n6:A06AB03
n3:H-Bond-Acceptor-Count
n4:271B5634-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5635-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B562F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5630-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5632-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5631-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5633-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
117-10-2
n3:category
n3:Bioavailability
n4:271B563A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B563C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B563D-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B563E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5639-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5638-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B563B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5629-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5636-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5637-363D-11E5-9242-09173F13E4C5